Skip to content
Clinical Trials – home
Verifiedinfo

Hopitaux Universitaires Paris Centre-Hopital Cochin

France 123 Bd de Port Royal, Batiment Copernic 5eme etage Service Oncologie, Paris, Paris, France,, 75014 Paris, France

  • 4 trials recruiting
  • Non-small cell lung cancer · Chronic obstructive pulmonary disease · Fallopian tube cancer
  • Adult patients

About Specializations

Hopitaux Universitaires Paris Centre-Hopital Cochin in Paris, France specialises in clinical trials of conditions such as Non-small cell lung cancer, Chronic obstructive pulmonary disease, Fallopian tube cancer, Ovarian cancer, and other specialisations. This site conducts important research.

Main research areas of the site

Oncology

The medical center is at the forefront of oncology research, with a particular focus on non-small cell lung cancer (NSCLC). The institution is dedicated to advancing treatment options for patients with RET fusion-positive NSCLC, a subtype characterized by specific genetic alterations.

  • Advanced or Metastatic RET Fusion-Positive NSCLC
  • Targeted Therapies
  • Precision Medicine

Through its research, the center is contributing to the development of novel therapeutic strategies, such as the use of selpercatinib, which is being compared to traditional platinum-based therapies in clinical trials. This work is pivotal in enhancing the efficacy and personalization of cancer treatments.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
123 Bd de Port Royal, Batiment Copernic 5eme etage Service Oncologie, Paris, Paris, France,75014 ParisFrance
Recruiting now
4 trials
Conditions studied
7
Partner status
Verified

More sites in ParisFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

6 clinical trials

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:Pfizer Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Eli Lilly & Co.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Pfizer Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Intergroupe Francophone De Cancerologie Thoracique
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Amoxicillin
  • Sponsor:Assistance Publique Hopitaux De Paris
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Eli Lilly & Co.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.